Fig. 4From: A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controlsPCA (a) and PLS-DA (b) for the FMS patients relative to the young controls, based on the quantified 20 metabolitesBack to article page